Cardlytics, Inc. filed an 8-K current report on November 16, 2026, disclosing a plan to reduce its workforce by approximately 30 full-time employees as part of a broader cost-reduction initiative.

Key Highlights

  • Workforce reduction: Approximately 30 full-time employees, representing approximately 15% of the company's current workforce, will be cut under the plan.
  • Annualized savings: The plan and other cost-reduction measures are expected to reduce operating expenses by approximately $12.2 million on an annualized basis.
  • Restructuring charges: The company estimates non-recurring charges of approximately $0.7 million, consisting of severance payments and related costs.
  • Timeline: The majority of restructuring charges are expected to be incurred in the fourth quarter ending December 31, 2026.
  • Completion: Implementation of the workforce reduction, including cash payments, is expected to be substantially complete by the end of the fourth quarter ending December 31, 2026.

Cardlytics Announces Cost-Reduction Plan With 15% Workforce Cut

According to the filing, Cardlytics, Inc. (NASDAQ:CDLX) announced on November 16, 2026, a plan to reduce its workforce by approximately 30 full-time employees, which represents approximately 15% of the company's current workforce. The company disclosed that the plan "is intended to optimize the Company's cost structure and is part of a broader cost-reduction initiative that also includes measures beyond full-time employee reductions."

The company reported that the combined effect of the workforce reduction and other cost-reduction measures being implemented is expected to reduce operating expenses by approximately $12.2 million on an annualized basis. In connection with the workforce reduction specifically, Cardlytics estimates it will incur non-recurring charges of approximately $0.7 million, consisting of severance payments and related costs, according to the filing.

The filing states that the majority of restructuring charges are expected to be incurred in the fourth quarter ending December 31, 2026, and that the implementation of the workforce reduction, including cash payments, is expected to be substantially complete by the end of that same quarter. The 8-K was signed by David Evans, Chief Financial Officer and Principal Financial and Accounting Officer. The filing contains forward-looking statements that the company notes are subject to risks and uncertainties, with actual results potentially differing materially from those stated.

What Was Disclosed

Cardlytics filed an 8-K on November 16, 2026, under Item 2.05, disclosing a workforce reduction plan affecting approximately 30 full-time employees (about 15% of its workforce), with estimated restructuring charges of approximately $0.7 million and expected annualized operating expense savings of approximately $12.2 million.